Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1186/1758-5996-1-25 http://repositorio.unifesp.br/handle/11600/31124 |
Resumo: | Type 1A diabetes mellitus (T1ADM) is a progressive autoimmune disease mediated by T lymphocytes with destruction of beta cells. Up to now, we do not have precise methods to assess the beta cell mass, in vivo or ex-vivo. the studies about its genetic susceptibility show strong association with class II antigens of the HLA system (particularly DQ). Others genetics associations are weaker and depend on the population studied. A combination of precipitating events may occur at the beginning of the disease. There is a silent loss of immune-mediated beta cells mass which velocity has an inverse relation with the age, but it is influenced by genetic and metabolic factors. We can predict the development of the disease primarily through the determination of four biochemically islet auto antibodies against antigens like insulin, GAD65, IA2 and Znt8. Beta cell destruction is chronically progressive but at clinical diagnosis of the disease a reserve of these cells still functioning. the goal of secondary disease prevention is halt the autoimmune attack on beta cells by redirecting or dampening the immune system. It is remains one of the foremost therapeutic goals in the T1ADM. Glycemic intensive control and immunotherapeutic agents may preserve beta-cell function in newly diagnosed patients with T1ADM. It may be assessed through C-peptide values, which are important for glycemic stability and for the prevention of chronic complications of this disease. This article will summarize the etiopathogenesis mechanisms of this disease and the factors can influence on residual C-peptide and the strategies to it preservation. |
id |
UFSP_1dbc69871a0b297e2f054bb17cfc90bd |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/31124 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell functionType 1A diabetes mellitus (T1ADM) is a progressive autoimmune disease mediated by T lymphocytes with destruction of beta cells. Up to now, we do not have precise methods to assess the beta cell mass, in vivo or ex-vivo. the studies about its genetic susceptibility show strong association with class II antigens of the HLA system (particularly DQ). Others genetics associations are weaker and depend on the population studied. A combination of precipitating events may occur at the beginning of the disease. There is a silent loss of immune-mediated beta cells mass which velocity has an inverse relation with the age, but it is influenced by genetic and metabolic factors. We can predict the development of the disease primarily through the determination of four biochemically islet auto antibodies against antigens like insulin, GAD65, IA2 and Znt8. Beta cell destruction is chronically progressive but at clinical diagnosis of the disease a reserve of these cells still functioning. the goal of secondary disease prevention is halt the autoimmune attack on beta cells by redirecting or dampening the immune system. It is remains one of the foremost therapeutic goals in the T1ADM. Glycemic intensive control and immunotherapeutic agents may preserve beta-cell function in newly diagnosed patients with T1ADM. It may be assessed through C-peptide values, which are important for glycemic stability and for the prevention of chronic complications of this disease. This article will summarize the etiopathogenesis mechanisms of this disease and the factors can influence on residual C-peptide and the strategies to it preservation.Universidade Federal de São Paulo, Dept Med, Div Endocrinol, São Paulo, SP, BrazilUniv Estado Rio de Janeiro, Dept Med, Diabet Div, Rio de Janeiro, GB, BrazilUniversidade Federal de São Paulo, Dept Med, Div Endocrinol, São Paulo, SP, BrazilWeb of ScienceBiomed Central LtdUniversidade Federal de São Paulo (UNIFESP)Universidade do Estado do Rio de Janeiro (UERJ)Dib, Sergio A. [UNIFESP]Gomes, Marilia B.2016-01-24T13:52:00Z2016-01-24T13:52:00Z2009-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion8application/pdfhttp://dx.doi.org/10.1186/1758-5996-1-25Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 1, 8 p., 2009.10.1186/1758-5996-1-25WOS000207918200025.pdf1758-5996http://repositorio.unifesp.br/handle/11600/31124WOS:000207918200025engDiabetology & Metabolic Syndromeinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-07T11:03:34Zoai:repositorio.unifesp.br/:11600/31124Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-07T11:03:34Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function |
title |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function |
spellingShingle |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function Dib, Sergio A. [UNIFESP] |
title_short |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function |
title_full |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function |
title_fullStr |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function |
title_full_unstemmed |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function |
title_sort |
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function |
author |
Dib, Sergio A. [UNIFESP] |
author_facet |
Dib, Sergio A. [UNIFESP] Gomes, Marilia B. |
author_role |
author |
author2 |
Gomes, Marilia B. |
author2_role |
author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Universidade do Estado do Rio de Janeiro (UERJ) |
dc.contributor.author.fl_str_mv |
Dib, Sergio A. [UNIFESP] Gomes, Marilia B. |
description |
Type 1A diabetes mellitus (T1ADM) is a progressive autoimmune disease mediated by T lymphocytes with destruction of beta cells. Up to now, we do not have precise methods to assess the beta cell mass, in vivo or ex-vivo. the studies about its genetic susceptibility show strong association with class II antigens of the HLA system (particularly DQ). Others genetics associations are weaker and depend on the population studied. A combination of precipitating events may occur at the beginning of the disease. There is a silent loss of immune-mediated beta cells mass which velocity has an inverse relation with the age, but it is influenced by genetic and metabolic factors. We can predict the development of the disease primarily through the determination of four biochemically islet auto antibodies against antigens like insulin, GAD65, IA2 and Znt8. Beta cell destruction is chronically progressive but at clinical diagnosis of the disease a reserve of these cells still functioning. the goal of secondary disease prevention is halt the autoimmune attack on beta cells by redirecting or dampening the immune system. It is remains one of the foremost therapeutic goals in the T1ADM. Glycemic intensive control and immunotherapeutic agents may preserve beta-cell function in newly diagnosed patients with T1ADM. It may be assessed through C-peptide values, which are important for glycemic stability and for the prevention of chronic complications of this disease. This article will summarize the etiopathogenesis mechanisms of this disease and the factors can influence on residual C-peptide and the strategies to it preservation. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-01-01 2016-01-24T13:52:00Z 2016-01-24T13:52:00Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1186/1758-5996-1-25 Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 1, 8 p., 2009. 10.1186/1758-5996-1-25 WOS000207918200025.pdf 1758-5996 http://repositorio.unifesp.br/handle/11600/31124 WOS:000207918200025 |
url |
http://dx.doi.org/10.1186/1758-5996-1-25 http://repositorio.unifesp.br/handle/11600/31124 |
identifier_str_mv |
Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 1, 8 p., 2009. 10.1186/1758-5996-1-25 WOS000207918200025.pdf 1758-5996 WOS:000207918200025 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Diabetology & Metabolic Syndrome |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
8 application/pdf |
dc.publisher.none.fl_str_mv |
Biomed Central Ltd |
publisher.none.fl_str_mv |
Biomed Central Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268316504555520 |